Allergy test

4 trials 1 recruiting MedDRA PT
4 Registered trials
1 Recruiting
2 Unique sponsors
9 Unique IMPs
3 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 3
V Various (ATC V) 3
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 7 substances
Supportive / diluent 1 substance
Penicillin 1 substance
Phase II: 3 Phase IV: 1

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase II

3 trials
  • Inmunotek S.L. Commercial
    HISTAMINE DIHYDROCHLORIDE; LEPIDOGLYPHUS DESTRUCTOR EXTRACT; SODIUM CHLORIDE
    2023-509541-13-00 1 country 2024 n=30
    Ended
  • Inmunotek S.L. Commercial
    DACTYLIS GLOMERATA POLLEN EXTRACT, ENRICHED; HISTAMINE DIHYDROCHLORIDE; PHLEUM PRATENSE POLLEN EXTRACT, ENRICHED; SODIUM CHLORIDE
    2024-514215-98-00 1 country 2024 n=30
    Ended
  • Inmunotek S.L. Commercial
    HISTAMINE HYDROCHLORIDE; QUERCUS ILEX ALLERGEN EXTRACT; QUERCUS ROBUR POLLEN EXTRACT; SODIUM CHLORIDE
    2024-515189-14-00 1 country 2023 n=30
    Ended

Phase IV

1 trial
  • Gentofte Hospital Academic
    AMOXICILLIN TRIHYDRATE
    2025-520888-41-00 2 countries 2025 n=160
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Inmunotek S.L. Commercial 3 Phase II 0
Gentofte Hospital Academic 1 Phase IV 1
New trials by year
2023
1
2024
2
2025
1
← All indication landscapes